Cargando…
Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL(pro) inhibitors
Since the emergence of the severe acute respiratory syndrome (SARS) to date, neither an effective antiviral drug nor a vaccine against SARS is available. However, it was found that a mixture of two HIV-1 proteinase inhibitors, lopinavir and ritonavir, exhibited some signs of effectiveness against th...
Autores principales: | Nukoolkarn, Veena, Lee, Vannajan Sanghiran, Malaisree, Maturos, Aruksakulwong, Ornjira, Hannongbua, Supot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094092/ https://www.ncbi.nlm.nih.gov/pubmed/18706430 http://dx.doi.org/10.1016/j.jtbi.2008.07.030 |
Ejemplares similares
-
Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021) -
Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
por: Chong, Wei Lim, et al.
Publicado: (2023) -
Structural Basis of Specific Glucoimidazole and Mannoimidazole Binding by Os3BGlu7
por: Nutho, Bodee, et al.
Publicado: (2020) -
Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor
por: Al-Nema, Mayasah, et al.
Publicado: (2020)